文献速递神经肿瘤

假包膜切除预防无功能垂体神经内分泌肿瘤复发:一项随访超过5年的回顾性单中心研究

Pseudocapsular resection to prevent recurrence in nonfunctioning pituitary neuroendocrine tumors: a retrospective, single-center study with more than 5 years of follow-up.
PubMed 文献 · J Neurosurg · 2024-08-02

该回顾性单中心研究纳入132例无功能垂体神经内分泌肿瘤(NF-PitNETs)患者,均行肿瘤全切除,随访超过5年。分为假包膜全切除组(n=67)和非假包膜切除组(n=65,包括部分切除、未切除、无假包膜或术中无法识别者)。主要观察复发率和复发部位。结果:非假包膜切除组2例(3.1%)海绵窦复发、5例(7.7%)垂体窝复发;假包膜切除组2例(3.0%)海绵窦复发、垂体窝0例复发。垂体窝复发在非假包膜切除组更常见(p=0.0267)。多因素回归显示假包膜切除是降低垂体窝复发率的显著因素(p=0.0107)。结论:假包膜切除可能降低肿瘤复发率,改善NF-PitNETs的长期管理。

要点

  • 假包膜切除可能降低无功能垂体神经内分泌肿瘤的长期复发率。
  • 垂体窝复发在非假包膜切除组更常见(p=0.0267)。
  • 多因素分析显示假包膜切除是降低垂体窝复发的显著因素(p=0.0107)。

核心结论

  • 假包膜切除可能降低无功能垂体神经内分泌肿瘤的复发率,并改善长期随访中的管理。

研究设计与样本

  • 回顾性单中心研究,纳入132例接受肿瘤全切除且术后随访超过5年的无功能垂体神经内分泌肿瘤患者。
  • 患者分为假包膜全切除组(n=67)和非假包膜切除组(n=65),后者包括部分假包膜切除、未切除、无假包膜或术中无法识别假包膜者。

主要发现

  • 非假包膜切除组中,2例(3.1%)发生海绵窦复发,5例(7.7%)发生垂体窝复发。
  • 假包膜切除组中,2例(3.0%)发生海绵窦复发,0例发生垂体窝复发。
  • 垂体窝复发在非假包膜切除组比假包膜切除组更常见(p=0.0267)。
  • 多因素回归分析显示,假包膜切除是降低垂体窝肿瘤复发率的显著因素(p=0.0107)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pseudocapsular resection is a well-recognized, useful approach to achieve endocrinological remission in functioning pituitary neuroendocrine tumors (PitNETs). However, its advantage in nonfunctioning PitNETs (NF-PitNETs) has not been established. This study aimed to clarify the contribution of pseudocapsular resection to the prevention of NF-PitNET recurrence in long-term follow-up. METHODS: This retrospective study included 132 patients who underwent total tumor removal and were followed for more than 5 years after surgery. The patients were categorized into those who underwent total pseudocapsular resection (n = 67) and those who did not (n = 65). The nonpseudocapsule (nonpseudocap) resection group included patients who underwent partial pseudocapsular resection and those in whom the pseudocapsule was not resected, did not exist, or could not be identified during surgery. The main outcome measures were the tumor recurrence rate and site of recurrence. RESULTS: In the nonpseudocap resection group, 2 patients (3.1%) had tumor recurrence in the cavernous sinus and 5 (7.7%) had tumor recurrence in the pituitary fossa. In the pseudocapsule (pseudocap) resection group, only 2 patients (3.0%) had tumor recurrence in the cavernous sinus and 0 patients had tumor recurrence in the pituitary fossa. Tumor recurrence in the pituitary fossa was more likely to occur in the nonpseudocap resection group than in the pseudocap resection group (p = 0.0267). Multivariate regression analysis revealed that pseudocapsular resection was a significant factor for reducing the tumor recurrence rate in the pituitary fossa (p = 0.0107). CONCLUSIONS: Pseudocapsular resection may reduce the rate of tumor recurrence and improve the management of NF-PitNETs in long-term follow-up.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kinoshita Y, Taguchi A, Yamasaki F, et al. Pseudocapsular resection to prevent recurrence in nonfunctioning pituitary neuroendocrine tumors: a retrospective, single-center study with more than 5 years of follow-up. J Neurosurg. 2024. PMID: 39094191. doi:10.3171/2024.4.JNS2432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。